Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Effects of Hyperglycemia on the Vascular System

Artificial Pancreas Systems: The Future of Diabetes Management?

Adiponectin and Diabetes

Diabetic Hypoglycemia Etiology

Red Blood Cell Morphology Changes in Diabetes

Diabetic Nephropathy Symptoms

What Causes Diabetes?

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Diabetes and Mucormycosis

What is Diabetes?

Diabetic Emergencies: What to Do

See more featured articles »

Diabetic Mastopathy Diagnosis

Diabetes Types

What is Diabetic Nephropathy?

Diabetic Foot Problems

Genetic Testing for Diabetes

Diabetes in Men

Diabetes and Pregnancy

Diabetes and Skin Problems

What are Nightmares and Why Do They Occur?

What is HbA1c?

Diabetic Neuropathy Diagnosis

Diabetic Retinopathy Treatments

Pins and Needles and Diabetes

Is a Plant-Based Diet Good for Type 2 Diabetes?

Diabetic Neuropathy Symptoms

What is Diabetic Neuropathy?

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Diabetes Screening

Does the Keto Diet Increase the Risk of Diabetes?

Supplements for Diabetes

The Future of Diabetes Treatment

What is HbA1C Testing?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Alcohol and Diabetes

Diabetes Risk Factors

How does Gestational Diabetes Affect the Baby?

Diabetic Coma Treatments

Animals That Can Detect Hypoglycemia

Diabetes Management

Advanced Diabetic Ketoacidosis

Vitamin D and Type 2 Diabetes

COVID-19 and Diabetes

What is Diabetic Retinopathy?

Understanding MODY 5: A Rare Genetic Form of Diabetes

What is Diabetic Hypoglycemia?

How Does Semaglutide Work to Lose Weight?

What is Diabetic Ketoacidosis?

Can I reverse my prediabetes naturally

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Diabetic Retinopathy Diagnosis

Walking After Meals: Small Habit, Big Metabolic Gains

Low Sugar Foods for Diabetes

What is a Diabetic Coma?

Hypoglycemic Unawareness

Diabetic Nephropathy Treatment

The Impact of Glucagon on Diabetes Management

Diabetes Pathophysiology

Diabetes and Sleep

Diabetes Diagnosis

Epigenetic Mechanisms in Type 2 Diabetes

Diabetic Retinopathy Symptoms

Diabetes Complications

Diabetic Coma Severe Hypoglycemia

Diabetic Ketoacidosis Causes

How Baking Soda Affects People with Type 2 Diabetes

Diabetic Mastopathy: Complication of Diabetes Mellitus

Diabetes Symptoms

Diabetic Hypoglycemia Treatments

Cause of Diabetic Coma

Causes of Foot Pain

History of Diabetes

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Diabetes in Men versus Women

Diabetic Retinopathy Risk Factors

Research into a Cure for Diabetes

Diabetic Neuropathy Treatments

Diabetes and Wound Healing

Treatment and Prognosis for Diabetic Mastopathy

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetes and Periodontitis

What Causes Diabetic Nephropathy (Kidney Disease)?

Nonketotic Hyperosmolar Coma

Diabetic Neuropathy Pathogenesis

Diabetes and Vision

The Risks of Prediabetes

Risks to Infants of Diabetic Mothers

Latest Diabetes News and Research

AI creates detailed map of fat and muscle distribution to predict major health risks

Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height.

5 May 2026

U.S. bariatric surgery rates drop significantly amid GLP-1 surge

The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery improves outcomes for patients with obesity and chronic kidney disease

Metabolic and bariatric surgery, also known as weight-loss surgery, dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events and death, according to new research presented here today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

GLP-1 use surges as surgery rates drop for severe obesity

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially -- from less than 4,600 prescriptions in 2018 to more than 1.4 million in 2025 -- according to a new real-world analysis presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery costs significantly less than GLP-1 drugs over two years

A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery is costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according to a new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Study links antimicrobial peptides to amyloid disease and neurodegeneration

For decades, antimicrobial peptides (AMPs) and amyloid-forming peptides were studied in largely separate contexts.

5 May 2026

Study reveals epigenetic adaptation of beta cells across lifespan and disease

As people age, most maintain normal blood sugar even as insulin resistance tends to rise. New research suggests that pancreatic beta cells help meet this demand through gradual epigenetic changes in regulatory regions of the genome that support beta-cell identity and function.

5 May 2026

GLP-1 drugs combined with surgery yield superior weight loss results

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

AI-driven model predicts type 1 diabetes risk with greater accuracy

Researchers use machine learning and genetic analysis to uncover type 1 diabetes risk factors, improving prediction accuracy and identifying patient subtypes.

5 May 2026

A new tool that predicts obesity-related disease risk beyond BMI

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment targeting beyond traditional BMI metrics.

5 May 2026

Blood tests years before pregnancy predict risk of hypertension

Pre-pregnancy blood biomarkers linked to hypertension risk highlight the potential for early intervention in managing hypertensive disorders of pregnancy.

5 May 2026

Virginia Tech researcher wins NIH award to study metabolic brain health

Mary Elizabeth Baugh, a research scientist with Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded a National Institutes of Health Mentored Research Scientist Development Award to study how metabolic health influences the brain systems that shape what and how we eat.

4 May 2026

Learn B.E. F.A.S.T. to recognize stroke signs and save lives

A stroke can change a life in an instant. In the minutes after symptoms begin, quick action can help protect the brain, reduce long-term disability and save a life, according to the American Stroke Association, a division of the American Heart Association.

4 May 2026

How a common gut bacterium may protect health

Akkermansia muciniphila's impact on immunity and pregnancy outcomes underscores its promise as a probiotic, with implications for infectious disease treatment.

4 May 2026

A more accurate tool for assessing Arsenic toxicity

Public health experts estimate that more than 200 million people worldwide are exposed to arsenic through contaminated drinking water. Scientists know long-term exposure to arsenic is associated with increased risk of chronic illnesses like cancer and cardiovascular disease, but there hasn't been a reliable way to track these exposures and fully understand their effects on the body and the mechanisms behind them.

4 May 2026

Child health experts launch GenHEART to tackle Australia's obesity crisis

Heart health, diet, exercise and sleep will be targeted under a multi-pronged strategy by child health experts to address Australia's obesity crisis.

4 May 2026

Semaglutide as a promising new treatment for alcohol use disorder

Research indicates semaglutide can significantly decrease alcohol consumption and cravings in individuals with comorbid obesity and alcohol use disorder.

4 May 2026

Five-target drug beats GLP-1/GIP therapy in obese diabetic mice

A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing cells while activating PPARα/γ/δ pathways. In obese and insulin-resistant mice, the compound reduced body weight, food intake, and hyperglycaemia more effectively than semaglutide or GLP-1R–GIPR co-agonism, while remaining a preclinical finding.

30 Apr 2026

New genetic risk report reveals hidden heart disease risk before symptoms appear

Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using large U.S.-based biobank data. The clinically orderable report may help identify inherited cardiovascular risk that traditional clinical markers can miss, although broader prospective validation is still needed.

30 Apr 2026

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

30 Apr 2026